Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01516463

Using Santyl or Bacitracin on Second Degree Burns

Comparison of Collagenase Santyl® Ointment With Antibiotic Ointment in the Outpatient Care of Minor Partial Thickness Burns

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Healthpoint · Industry
Sex
All
Age
2 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Subjects who have minor, second degree burns may be enrolled in this study. Subjects will receive either Santyl ointment or bacitracin ointment to apply to the burn until it heals. Bandages will be used to keep the burn covered while it heals. Second degree burns generally leave a scar. Once the burn heals, lotion and an appropriate bandage will be used to try to minimize the appearance of a scar. The study hypothesis is that burns treated with Santyl will have a better scar appearance than burns treated with bacitracin. Subjects enrolled in this study will make once a week visits to the University of Kansas Medical Center outpatient burn clinic until the burn heals. The burn will be assessed for healing at these visits. Once healed, visits to the clinic will be every 1-3 months for up to 1 year. At these visits, the appearance of the scar will be evaluated

Conditions

Interventions

TypeNameDescription
DRUGCollagenase SantylApplied topically (2 mm thickness once daily)
BIOLOGICALBacitracinApplied topically (2 mm thickness) once daily

Timeline

Start date
2012-03-01
Primary completion
2013-06-01
Completion
2013-12-01
First posted
2012-01-24
Last updated
2012-05-16

Source: ClinicalTrials.gov record NCT01516463. Inclusion in this directory is not an endorsement.